Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7842)
All Articles published online
|
Publishing Process of This Article
|
Sep 26, 2015 (publication date) through May 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Becher PM, Fluschnik N, Blankenberg S, Westermann D. Challenging aspects of treatment strategies in heart failure with preserved ejection fraction: “Why did recent clinical trials fail?”. World J Cardiol 2015; 7(9): 544-554 [PMID: 26413231 DOI: 10.4330/wjc.v7.i9.544] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v7/i9/544.htm |
| Number | Citing Articles |
| 1 |
Christoph Maack, Michael Lehrke, Johannes Backs, Frank R Heinzel, Jean-Sebastien Hulot, Nikolaus Marx, Walter J Paulus, Patrick Rossignol, Heinrich Taegtmeyer, Johann Bauersachs, Antoni Bayes-Genis, Dirk Brutsaert, Heiko Bugger, Kieran Clarke, Francesco Cosentino, Gilles De Keulenaer, Alessandra Dei Cas, Arantxa González, Martin Huelsmann, Guido Iaccarino, Ida Gjervold Lunde, Alexander R Lyon, Piero Pollesello, Graham Rena, Niels P Riksen, Giuseppe Rosano, Bart Staels, Linda W van Laake, Christoph Wanner, Dimitrios Farmakis, Gerasimos Filippatos, Frank Ruschitzka, Petar Seferovic, Rudolf A de Boer, Stephane Heymans. Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association–European Society of Cardiology. European Heart Journal 2018; 39(48): 4243 doi: 10.1093/eurheartj/ehy596
|
| 2 |
L.V. Zhuravlyova, T.A. Rogachova, N.V. Sokolnikova. Heart Failure In Patients With Diabetic Cardiomyopathy: Pathogenesis, Diagnosis, Treatment. Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2019; 2019(2): 12 doi: 10.15407/internalmed2019.02.012
|
| 3 |
Vincenzo B. Polsinelli, Sanjiv J. Shah. Advances in the pharmacotherapy of chronic heart failure with preserved ejection fraction: an ideal opportunity for precision medicine. Expert Opinion on Pharmacotherapy 2017; 18(4): 399 doi: 10.1080/14656566.2017.1288717
|
| 4 |
Jonathan P. Law, Luke Pickup, Jonathan N. Townend, Charles J. Ferro. Vive les Differences!—A case for optimism in the treatment of patients with heart failure and preserved ejection fraction?. International Journal of Clinical Practice 2019; 73(6): e13307 doi: 10.1111/ijcp.13307
|
| 5 |
Andrew Xanthopoulos, Grigorios Giamouzis, John Skoularigis, Filippos Triposkiadis. Heart failure with reduced, mildly reduced, or preserved left ventricular ejection fraction: Has reasoning been lost?. World Journal of Cardiology 2022; 14(7): 438-445 doi: 10.4330/wjc.v14.i7.438
|
| 6 |
Qi Zhang, Jun Xiang, Qian Fan, Pingping Wu, Qian Wang, Xiji Xiao, Aizhi Wu, Li Rong, Yumei Wang, Cuixian Zhang. Preliminary investigation on the analysis of the whole components of Pogejiuxin decoction and its formulation pattern based on ultrahigh‐performance liquid chromatography with quadrupole time‐of‐flight mass spectrometry. Rapid Communications in Mass Spectrometry 2024; 38(9) doi: 10.1002/rcm.9727
|
| 7 |
Jin Joo Park, Hong-Mi Choi, In-Chang Hwang, Jun-Bean Park, Jae-Hyeong Park, Goo-Yeong Cho. Myocardial Strain for Identification of β-Blocker Responders in Heart Failure with Preserved Ejection Fraction. Journal of the American Society of Echocardiography 2019; 32(11): 1462 doi: 10.1016/j.echo.2019.06.017
|
| 8 |
Alberto Aimo, Michele Senni, Andrea Barison, Giorgia Panichella, Claudio Passino, Antoni Bayes-Genis, Michele Emdin. Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin. Heart Failure Reviews 2022; 28(1): 179 doi: 10.1007/s10741-022-10228-8
|
| 9 |
Minjae Yoon, Sung-Ji Park, Byung-Su Yoo, Dong-Ju Choi. The effect of sustained-release CARvedilol in patients with hypErtension and heart failure with preserved ejection fraction: a study protocol for a pilot randomized controlled trial (CARE-preserved HF). Frontiers in Cardiovascular Medicine 2024; 11 doi: 10.3389/fcvm.2024.1375003
|
| 10 |
L.V. Zhuravlyova, N.V. Sokolnikova, T.A. Rogachova. Heart failure in patients with diabetic cardiomyopathy: modern methods of treatment. Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2020; 2020(1): 22 doi: 10.15407/internalmed2020.01.022
|
| 11 |
Pan Gao, Mengying Cao, Xueli Jiang, Xiaolin Wang, Guoping Zhang, Xinru Tang, Chunjie Yang, Issei Komuro, Junbo Ge, Liliang Li, Yunzeng Zou. Cannabinoid Receptor 2-Centric Molecular Feedback Loop Drives Necroptosis in Diabetic Heart Injuries. Circulation 2023; 147(2): 158 doi: 10.1161/CIRCULATIONAHA.122.059304
|
| 12 |
Tianshu Yang, Huiyan Qu, Xiaolong Song, Qian Liu, Xiaoli Yang, Jijie Xu, Tao Yang, Zhenzhen Lan, Wanjing Sha, Hua Zhou. Luhong Granules Prevent Ventricular Remodelling after Myocardial Infarction by Reducing the Metabolites TMAO and LPS of the Intestinal Flora. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/8937427
|
| 13 |
Juan David López-Ponce de León, Juan Esteban Gómez-Mesa, Clara Saldarriaga, Luis Eduardo Echeverría, Alejandro Posada-Bastidas, Juan Camilo García, Alejandro David Ochoa-Morón, Balkis Rolong, Fernando Manzur-Jatin, José Ignacio Mosquera-Jiménez, Oscar Alfredo Pacheco-Jiménez, Álvaro Hernán Rodríguez-Cerón, Patricia Rodríguez-Gómez, Fernando Rivera-Toquica, Alex Rivera-Toquica. Prevalence, Clinical Characteristics, and Prognostic Impact of Kidney Disease on Heart Failure Patients: An Observational Study of the Colombian Heart Failure Registry. Cardiorenal Medicine 2023; : 292 doi: 10.1159/000530852
|